In addition, SLC26A2 and SLC6A14 mRNA levels have been used as part of a seven gene panel yielding rates of correct prediction, sensitivity, and specificity higher than that with previously available diagnostic indices for ulcerative colitis, Crohn's disease, and irritable bowel syndrome [40]. This evidence concerns the gene SLC26A2 and Crohn disease.